Gut microbiome in digestive health: a new frontier in research

January 04, 2019

Bethesda, MD (Jan. 3, 2019)-- Research on the gut microbiome is one of the most promising areas of science today. In a new special issue of Clinical Gastroenterology and Hepatology, the American Gastroenterological Association (AGA) has taken the deep-dive into the gut microbiome that both scientists and the public are looking for to help them better understand the effects of the microbiome on health and disease. Clinical Gastroenterology and Hepatology is the clinical practice journal of the AGA.

Research published in the special issue, "The Gut Microbiome & Digestive Health - A New Frontier," studies, analyzes and interprets gut microbiome data for clinicians, examines the possible role of the microbiome in digestive disease, and takes a robust look at microbiome-directed therapies for the past, present and future. Additionally, this issue provides a clinical context for translational and basic researchers engaged in the microbiome, facilitating further research that makes meaningful progress towards unravelling the mysteries of some of our most complex diseases and offers new therapeutic options that would allow us to safely and effectively improve patient outcomes.

Learn more about gut microbiome analytics and how the gut microbiome relates to aspects of nutrition, probiotics, the liver and gut-brain axis at http://www.gastro.org/microbiome. Clinical Gastroenterology and Hepatology also hosts a specially curated collection on the microbiome, through which you can stay abreast of the latest research published and sign up for alerts.

Visit the AGA Center for Gut Microbiome Research & Education for the latest in research and education and to learn more about the AGA's NIH-funded Fecal Microbiota Transplantation (FMT) National Registry. AGA's GI Patient Center also host specific patient-education pages written by AGA experts, on the related topics of probiotics and fecal microbiota transplantation, presented in an easy-to-read and easy-to-understand format for all patients.

Introduction to the issue Microbiome in specific diseasesMicrobiome-directed therapies: past, present and future
-end-
About the AGA Institute

The American Gastroenterological Association (AGA) is the trusted voice of the GI community. Founded in 1897, AGA has grown to include more than 16,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. https://www.gastro.org/ .

About Clinical Gastroenterology and Hepatology

The mission of Clinical Gastroenterology and Hepatology is to provide readers with a broad spectrum of themes in clinical gastroenterology and hepatology. This monthly peer-reviewed journal includes original articles as well as scholarly reviews, with the goal that all articles published will be immediately relevant to the practice of gastroenterology and hepatology. For more information, visit http://www.cghjournal.org.

Like AGA and Clinical Gastroenterology and Hepatology on Facebook.

Follow us on Twitter @AmerGastroAssn, @AGA_CGH

Follow AGA on LinkedIn.

Watch our videos on YouTube.

American Gastroenterological Association

Related Liver Disease Articles from Brightsurf:

Fatty liver disease despite a normal weight
Researchers from the University of Tsukuba found significant differences in the clinical presentation of non-obese patients with non-alcoholic fatty liver disease (NAFLD) based on their sex and body mass index.

Sobering reminder about liver disease
Alcohol's popularity and its central place in socialising in Australia obscures the dangers of excessive drinking and possible liver disease, Flinders University experts warn.

Giant leap in diagnosing liver disease
A collaborative team of Salk Institute and UC San Diego scientists have created a novel microbiome-based diagnostic tool that, with the accuracy of the best physicians, quickly and inexpensively identifies liver fibrosis and cirrhosis over 90 percent of the time in human patients.

Link between liver and heart disease could lead to new therapeutics
A newly published study of flies found that protecting liver function also preserves heart health.

Fatty liver disease is underdiagnosed in the US
According to an analysis published in Alimentary Pharmacology & Therapeutics, nonalcoholic fatty liver disease (NAFLD) is grossly underdiagnosed in the United States.

Possible new treatment strategy for fatty liver disease
Researchers at Karolinska Institutet in Sweden have identified a molecular pathway that when silenced could restore the normal function of immune cells in people with fatty liver disease.

Longevity protein SIRT6 also protects against fatty liver and fatty liver disease
SIRT6 regulates fat metabolism by activating another protein called peroxisome proliferator-activated receptor alpha (PPAR-alpha).

Fresh insights could lead to new treatments for liver disease
The fight against liver disease could be helped by the discovery of cells that cause liver scarring.

Better methods needed for predicting risk of liver disease
While blood samples can reliably identify people with a low risk of developing severe liver disease, better methods are needed in primary care for identifying people in most need of care.

Lab-on-a-chip may help identify new treatments for liver disease
Investigators have developed a 'lab on a chip' technology that can simulate different levels of non-alcoholic fatty liver disease progression.

Read More: Liver Disease News and Liver Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.